Matches in SemOpenAlex for { <https://semopenalex.org/work/W2400395246> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2400395246 endingPage "404" @default.
- W2400395246 startingPage "404" @default.
- W2400395246 abstract "AIM:To evaluate the immunity of chemically modified tumor cell vaccine.METHODS:Tumor cell vaccines (TCV) were prepared by incubating the live Ehrlich ascites tumor cells with concanavalin A-mitomycin C (ConA-MMC), mitomycin C (MMC), concanavalin A-glutaraldehyde (ConA-Glu), glutaraldehyde (Glu), or paraformaldehyde (Para), respectively. The whole cell or soluble forms of the vaccines were administered intraperitoneally into Kunming mice once a week for three times prior to the intraperitoneal inoculation of a lethal dose of live tumor cells. A second challenge with live tumor cells was given four weeks later. Survival and antibody production of the mice were analyzed.RESULTS:After the first challenge, the mice, received whole TCV of ConA-MMC, MMC (P < 0.01) and Glu (P < 0.05) promoted survival incidence than the controls. All the treated mice had the survival time prolonged. ConA-MMC vaccine treated mice had longer survival days than that of ConA-Glu ones (P < 0.05). For the soluble TCV immunized mice,those treated with vaccines of Para (P < 0.01), ConA-Para and ConA-Glu (P < 0.05) had longer survival periods compared with that of the controls. Following the second challenge, survival incidence of the mice received vaccines of ConA-MMC, MMC, ConA-Glu or Glu was significantly increased (P < 0.01). Moreover, all the treated mice had the survival time prolonged, and ConA-MMC vaccine treated mice had longer survival days than that of Para treated ones (P < 0.05). Antibodies against Ehrlich ascites tumor cells were found to be positive in sera of the mice treated with whole TCV of ConA-MMC.CONCLUSION:Ehrlich ascites tumor cells are immunogenic when treated with ConA-MMC, MMC, ConA-Glu, Glu or Para, which might act as safe and effective tumor vaccines with safety and effectiveness." @default.
- W2400395246 created "2016-06-24" @default.
- W2400395246 creator A5021814370 @default.
- W2400395246 date "1998-01-01" @default.
- W2400395246 modified "2023-10-16" @default.
- W2400395246 title "Immuno-protective effect of tumor cell vaccine on Kunming mice bearing Ehrlich ascites tumor" @default.
- W2400395246 cites W1481962978 @default.
- W2400395246 cites W1966554490 @default.
- W2400395246 cites W1973296161 @default.
- W2400395246 cites W2070966332 @default.
- W2400395246 cites W2084769283 @default.
- W2400395246 cites W2117312916 @default.
- W2400395246 cites W2128942611 @default.
- W2400395246 cites W2141894986 @default.
- W2400395246 cites W4249111413 @default.
- W2400395246 doi "https://doi.org/10.3748/wjg.v4.i5.404" @default.
- W2400395246 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4767737" @default.
- W2400395246 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11819331" @default.
- W2400395246 hasPublicationYear "1998" @default.
- W2400395246 type Work @default.
- W2400395246 sameAs 2400395246 @default.
- W2400395246 citedByCount "4" @default.
- W2400395246 crossrefType "journal-article" @default.
- W2400395246 hasAuthorship W2400395246A5021814370 @default.
- W2400395246 hasBestOaLocation W24003952461 @default.
- W2400395246 hasConcept C126322002 @default.
- W2400395246 hasConcept C141071460 @default.
- W2400395246 hasConcept C142724271 @default.
- W2400395246 hasConcept C159654299 @default.
- W2400395246 hasConcept C16685009 @default.
- W2400395246 hasConcept C19869320 @default.
- W2400395246 hasConcept C202751555 @default.
- W2400395246 hasConcept C203014093 @default.
- W2400395246 hasConcept C2777529624 @default.
- W2400395246 hasConcept C2778723968 @default.
- W2400395246 hasConcept C2779338040 @default.
- W2400395246 hasConcept C2780496750 @default.
- W2400395246 hasConcept C55493867 @default.
- W2400395246 hasConcept C71924100 @default.
- W2400395246 hasConcept C86803240 @default.
- W2400395246 hasConcept C98274493 @default.
- W2400395246 hasConceptScore W2400395246C126322002 @default.
- W2400395246 hasConceptScore W2400395246C141071460 @default.
- W2400395246 hasConceptScore W2400395246C142724271 @default.
- W2400395246 hasConceptScore W2400395246C159654299 @default.
- W2400395246 hasConceptScore W2400395246C16685009 @default.
- W2400395246 hasConceptScore W2400395246C19869320 @default.
- W2400395246 hasConceptScore W2400395246C202751555 @default.
- W2400395246 hasConceptScore W2400395246C203014093 @default.
- W2400395246 hasConceptScore W2400395246C2777529624 @default.
- W2400395246 hasConceptScore W2400395246C2778723968 @default.
- W2400395246 hasConceptScore W2400395246C2779338040 @default.
- W2400395246 hasConceptScore W2400395246C2780496750 @default.
- W2400395246 hasConceptScore W2400395246C55493867 @default.
- W2400395246 hasConceptScore W2400395246C71924100 @default.
- W2400395246 hasConceptScore W2400395246C86803240 @default.
- W2400395246 hasConceptScore W2400395246C98274493 @default.
- W2400395246 hasIssue "5" @default.
- W2400395246 hasLocation W24003952461 @default.
- W2400395246 hasLocation W24003952462 @default.
- W2400395246 hasLocation W24003952463 @default.
- W2400395246 hasLocation W24003952464 @default.
- W2400395246 hasOpenAccess W2400395246 @default.
- W2400395246 hasPrimaryLocation W24003952461 @default.
- W2400395246 hasRelatedWork W2001125651 @default.
- W2400395246 hasRelatedWork W2020444221 @default.
- W2400395246 hasRelatedWork W2046579970 @default.
- W2400395246 hasRelatedWork W2051308694 @default.
- W2400395246 hasRelatedWork W2064209295 @default.
- W2400395246 hasRelatedWork W2091176224 @default.
- W2400395246 hasRelatedWork W2118815427 @default.
- W2400395246 hasRelatedWork W2339913352 @default.
- W2400395246 hasRelatedWork W2382168621 @default.
- W2400395246 hasRelatedWork W2400395246 @default.
- W2400395246 hasVolume "4" @default.
- W2400395246 isParatext "false" @default.
- W2400395246 isRetracted "false" @default.
- W2400395246 magId "2400395246" @default.
- W2400395246 workType "article" @default.